According to the latest analysis by Future Market Insights (FMI), the demand for coronary stents, including portable variants, is expected to rise significantly in the coming years. Key factors driving this growth include the aging population and an increasing prevalence of cardiovascular diseases (CVDs), diabetes, obesity, and complex lesions. These risk factors underscore the critical role coronary stents play in modern cardiac care.
Coronary stents offer numerous benefits, including the enhancement of blood flow and prevention of further damage to the heart muscle. By alleviating symptoms of heart disease such as angina and shortness of breath, stents reduce the need for invasive coronary bypass surgeries. This makes stenting an attractive choice for surgeons and patients alike, as it is a minimally invasive procedure with relatively quick post-operative recovery times.
The growing acceptance of stenting as a preferred treatment method highlights its effectiveness in managing heart disease with lower surgical risks. As the global burden of heart-related conditions continues to escalate, innovative advancements in stent design and technology are poised to further improve outcomes, driving adoption and market growth.
A Comprehensive Full Report – https://www.futuremarketinsights.com/reports/coronary-stents-market
Key Takeaways:
- The demand for coronary stents is set to grow exponentially, driven by an aging population and a rising prevalence of cardiovascular diseases, diabetes, and obesity.
- Coronary stenting improves blood flow, mitigates heart muscle damage, and alleviates symptoms like angina and shortness of breath.
- The procedure is a minimally invasive alternative to coronary bypass surgery, offering faster recovery times.
- Surgeons increasingly prefer stents due to their efficacy and reduced patient risk.
As cardiovascular diseases remain a leading global health concern, the coronary stents market is positioned for sustained growth, transforming the way heart conditions are managed worldwide.
Key Drivers of Market Growth
- Increasing Prevalence of Cardiovascular Diseases: The growing incidence of conditions such as coronary artery disease (CAD), diabetes, and obesity is leading to a higher demand for coronary stenting procedures. This trend is particularly pronounced as these risk factors contribute significantly to heart-related ailments.
- Minimally Invasive Procedures: Stenting is favored by surgeons because it is a minimally invasive procedure that significantly improves blood flow, alleviates symptoms like angina and shortness of breath, and reduces the need for more invasive surgeries such as coronary bypass surgery.
- Technological Advancements: Innovations in stent technology, including bioresorbable vascular scaffolds and drug-eluting stents, are enhancing the effectiveness of treatments and expanding the range of applications for coronary stents.
- Hybrid Imaging Systems: The growing popularity of hybrid imaging systems that combine different modalities is anticipated to further boost market expansion by improving diagnostic accuracy and treatment outcomes.
- Government Initiatives: Increased government support and initiatives aimed at improving healthcare access are also contributing to market growth, particularly in regions with a high burden of cardiovascular diseases.
- Rising Healthcare Expenditures: As healthcare expenditures increase globally, there is greater investment in advanced medical technologies, including coronary stents, which supports market expansion.
Start-ups for Coronary Stents Market
Some key startups in the Coronary Stents market include-
- Silk Road Medical produces devices for Transcarotid artery revascularization (TAR) procedures for carotid artery disease. Their products include the EnRoute Transcarotid Neuroprotection and the EnRoute Stent system. The ENROUTE Transcarotid Stent is intended to be used in conjunction with the Transcarotid Neuroprotection System (NPS) during the TCAR procedure. A small incision is made just above the collar bone to expose the common carotid artery in which a flexible sheath is placed directly into the carotid artery and connected to a system that will reverse the flow of blood away from the brain to protect against fragments of plaque.
- Echopoint Medical is a leading developer of smart devices for monitoring coronary artery disease and microvascular dysfunction. The company is involved in the development of optical-fiber-based sensors that integrate into medical devices for monitoring cardiac health. It has developed its microcatheter device that uses nanomaterials and sensors that can be positioned into cardiovascular devices for detecting heart conditions by using iKOR technology.
Who are the Leading Players in the Coronary Stents Market?
The top Coronary Stents market players are constantly upgrading their offerings to help end users. They are investing in partnerships, acquisitions, collaborations, and new product launches to gain a competitive edge in the market. For instance:
- In April 2021, Abbott announced the launch of the coronary imaging platform Ultreon 1.0 Software powered by Al in Europe. The software has been launched with the aim to improve the detection of calcium-based blockages and measuring vessel diameter during coronary stenting procedures.
- In February 2021, Cardiovascular Systems Inc announced a partnership agreement with Chansu Vascular Technologies, LLC with an aim to develop peripheral and coronary drug-coated balloons for applications in drug-eluting stents.
Key Companies Profiled
- Abbott
- Medtronic
- Boston Scientific Corporation
- Terumo Corporation
- B Braun Melsungen AG
- Biotronik
- Stentys SA
- MicroPort Scientific Corporation
- C. R. Bard, Inc.
- Cook Medical
Key Segments Covered in the Coronary Stents Industry Analysis
By Product:
- Drug Eluting Stent (DES)
- Bare Metal Stent (BMS)
- Bioresorbable Vascular Stent (BVS)
By Raw Material:
- Cobalt-Chromium
- Stainless Steel
- Platinum – Chromium
- Nickel – Titanium
- Polymer
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Catheterization Laboratories
By Region:
- North America
- Latin America
- Brazil
- Western Europe
- Eastern Europe
- Asia Pacific Excluding Japan
- Japan
- Middle East and Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube